John Bushweller

John Bushweller

University of Virginia

H-index: 52

North America-United States

About John Bushweller

John Bushweller, With an exceptional h-index of 52 and a recent h-index of 25 (since 2020), a distinguished researcher at University of Virginia, specializes in the field of structural biology, chemical biology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Pharmacological inhibition of RAS overcomes FLT3 inhibitor resistance in FLT3-ITD+ AML through AP-1 and RUNX1

RUNX2 inhibition alters PAX3:: FOXO1 driven fusion-positive rhabdomyosarcoma cell state and growth

Combination therapies for treating cancer

N-MYC regulates cell survival via eIF4G1 in inv (16) acute myeloid leukemia

Gene regulatory network analysis predicts cooperating transcription factor regulons required for FLT3-ITD+ AML growth

P444: SINGLE CELL RNASEQ UNCOVERING THE ROLE OF A LEUKEMIC DRIVER GENE FUSION CBFΒ:: MYH11 IN THE LEUKEMIC–NICHE SIGNALING

The intrinsically disordered proteins MLLT3 (AF9) and MLLT1 (ENL)–multimodal transcriptional switches with roles in normal hematopoiesis, MLL fusion leukemia, and kidney cancer

3053–DEFINING THE GENE REGULATORY NETWORKS TARGETED BY RUNX1 AND FLT3 INHIBITORS

John Bushweller Information

University

Position

___

Citations(all)

10288

Citations(since 2020)

2675

Cited By

8399

hIndex(all)

52

hIndex(since 2020)

25

i10Index(all)

93

i10Index(since 2020)

58

Email

University Profile Page

University of Virginia

Google Scholar

View Google Scholar Profile

John Bushweller Skills & Research Interests

structural biology

chemical biology

Top articles of John Bushweller

Title

Journal

Author(s)

Publication Date

Pharmacological inhibition of RAS overcomes FLT3 inhibitor resistance in FLT3-ITD+ AML through AP-1 and RUNX1

Iscience

Daniel JL Coleman

Peter Keane

Paulynn S Chin

Luke Ames

Sophie Kellaway

...

2024/4/19

RUNX2 inhibition alters PAX3:: FOXO1 driven fusion-positive rhabdomyosarcoma cell state and growth

Cancer Research

Elizabeth A Mendes

Audrey L Chambers

Samantha J Weitzel

Michael Deel

Aanandi Munshi

...

2024/3/22

Combination therapies for treating cancer

2022/9/7

N-MYC regulates cell survival via eIF4G1 in inv (16) acute myeloid leukemia

Science Advances

Philomina Sona Peramangalam

Sridevi Surapally

Anthony J Veltri

Shikan Zheng

Robert Burns

...

2024/2/28

Gene regulatory network analysis predicts cooperating transcription factor regulons required for FLT3-ITD+ AML growth

Cell Reports

Daniel JL Coleman

Peter Keane

Rosario Luque-Martin

Paulynn S Chin

Helen Blair

...

2023/12/26

P444: SINGLE CELL RNASEQ UNCOVERING THE ROLE OF A LEUKEMIC DRIVER GENE FUSION CBFΒ:: MYH11 IN THE LEUKEMIC–NICHE SIGNALING

HemaSphere

Polina Derevyanko

Alexandra V Dolgikh

Minoo Ashtiani

Anja Krippner-Heidenreich

Ryan Nelson

...

2023/8/1

The intrinsically disordered proteins MLLT3 (AF9) and MLLT1 (ENL)–multimodal transcriptional switches with roles in normal hematopoiesis, MLL fusion leukemia, and kidney cancer

Ashish Kabra

John Bushweller

2022/1/15

3053–DEFINING THE GENE REGULATORY NETWORKS TARGETED BY RUNX1 AND FLT3 INHIBITORS

Experimental Hematology

Peter Cockerill

Salam Assi

Constanze Bonifer

John Bushweller

Paulynn Chin

...

2022/1/1

Regulome analysis in B-acute lymphoblastic leukemia exposes Core Binding Factor addiction as a therapeutic vulnerability

Nature Communications

Jason P Wray

Elitza M Deltcheva

Charlotta Boiers

Simon Е Richardson

Jyoti Bikram Chhetri

...

2022/11/21

Small-molecule inhibitors of the mll1 cxxc domain, an epigenetic reader of DNA methylation

ACS Medicinal Chemistry Letters

Hanuman P Kalmode

Izabella Podsiadly

Ashish Kabra

Adam Boulton

Prabhakar Reddy

...

2022/7/7

KIX domain determines a selective tumor-promoting role for EP300 and its vulnerability in small cell lung cancer

Science Advances

Kee-Beom Kim

Ashish Kabra

Dong-Wook Kim

Yongming Xue

Yuanjian Huang

...

2022/2/16

Unique role and vulnerability of EP300 KIX domain in small-cell lung cancer

bioRxiv

Kee-Beom Kim

Ashish Kabra

Dong-Wook Kim

Yongming Xue

Pei-Chi Hou

...

2021/6/3

TNF‐α signaling regulates RUNX1 function in endothelial cells

The FASEB Journal

Hannah AB Whitmore

Dhanesh Amarnani

Michael O'Hare

Santiago Delgado‐Tirado

Lucia Gonzalez‐Buendia

...

2021/2

The epigenetic eraser LSD1 lies at the apex of a reversible erythroid to myeloid cell fate decision

bioRxiv

Lei Yu

Greggory Myers

Chia-Jui Ku

Emily Schneider

Yu Wang

...

2021/1/14

The CBFβ-SMMHC/NRP1 Axis Regulates FLT3 and TGF-Beta Pathways in Inv (16) Acute Myeloid Leukemia

Blood

Mahesh Hegde

Mohd Hafiz Ahmad

Rui Li

Anneliese Carrascoso

Roger Mulet-Lazaro

...

2021/11/23

An erythroid-to-myeloid cell fate conversion is elicited by LSD1 inactivation

Blood, The Journal of the American Society of Hematology

Lei Yu

Greggory Myers

Chia-Jui Ku

Emily Schneider

Yu Wang

...

2021/11/4

Targeting runt-related transcription factor 1 prevents pulmonary fibrosis and reduces expression of severe acute respiratory syndrome coronavirus 2 host mediators

The American Journal of Pathology

Michael O'Hare

Dhanesh Amarnani

Hannah AB Whitmore

Miranda An

Claudia Marino

...

2021/7/1

Inhibition of the RUNX1-CBFβ transcription factor complex compromises mammary epithelial cell identity: a phenotype potentially stabilized by mitotic gene bookmarking

Oncotarget

Joshua T Rose

Eliana Moskovitz

Joseph R Boyd

Jonathan A Gordon

Nicole A Bouffard

...

2020/6/6

RUNX transcription factor mediated control of breast cancer stem cells

Journal of cellular physiology

Andrew J Fritz

Deli Hong

Joseph Boyd

Jason Kost

Kristiaan H Finstaad

...

2020/10

RUNX1 and RUNX2 transcription factors function in opposing roles to regulate breast cancer stem cells

Journal of cellular physiology

Andrew J Fritz

Deli Hong

Joseph Boyd

Jason Kost

Kristiaan H Finstaad

...

2020/10

See List of Professors in John Bushweller University(University of Virginia)